title: [Anti-androgen treatment of hirsutism with cyproterone acetate].
abstract: 22 female patients suffering from idiopathic hirsutism were treated according to Hammerstein's reversed sequential scheme over 12 months. During each treatment cycle of 21 days, the daily medication consisted of 1 coated tablet containing 0.035 mg ethinyl estradiol and 2 mg cyproterone acetate (Diane-35); in addition, the patients received one i.m. injection of 300 mg cyproterone acetate (Androcur-Depot) on the first day of each cycle. This therapy resulted in improvement of the disease in 19 of our patients (86.4%). The transitory, mild side effects observed did not require interruption of the treatment. The reversed sequential scheme making use of the depot form of CPA can successfully be administered in patients with hirsutism.
authors: Hautabteilung des Komitatskrankenhauses Kecskemét, Ungarn.
authors: M
authors: M
authors: Kása
authors: K
authors: K
authors: Egyedi
authors: S
authors: S
authors: Raffai
authors: L
authors: L
authors: Török
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000726:Androgen Antagonists; D003534:Cyproterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006628:Hirsutism / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular
chemical_list: D000726:Androgen Antagonists; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination; D003534:Cyproterone
vernacular_title: Antiandrogenbehandlung des Hirsutismus mit Cyproteronacetat.